{"id":2675,"date":"2021-02-05T08:36:39","date_gmt":"2021-02-05T07:36:39","guid":{"rendered":"https:\/\/cendoc.h12o.es\/blog\/?p=2675"},"modified":"2021-02-05T08:36:39","modified_gmt":"2021-02-05T07:36:39","slug":"adamts13-como-factor-de-pronostico-en-covid-19-y-h12o","status":"publish","type":"post","link":"https:\/\/cendoc.h12o.es\/blog\/2021\/02\/05\/adamts13-como-factor-de-pronostico-en-covid-19-y-h12o\/","title":{"rendered":"ADAMTS13 como factor de pron\u00f3stico en COVID-19 y H12O"},"content":{"rendered":"<p>\u201c<a href=\"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ijlh.13476\" target=\"_blank\" rel=\"noopener noreferrer\">Increased von Willebrand factor antigen and low ADAMTS13 activity are related to poor prognosis in covid\u201019 patients<\/a>\u201d <img loading=\"lazy\" decoding=\"async\" class=\" wp-image-3871 alignright\" src=\"https:\/\/coronavirusbiblioh12o.files.wordpress.com\/2020\/05\/logo12.jpg?w=258&amp;h=175\" alt=\"logo12\" width=\"258\" height=\"175\" data-attachment-id=\"3871\" data-permalink=\"https:\/\/coronavirusbiblioh12o.wordpress.com\/2020\/05\/06\/7-mas-del-h12o\/logo12\/\" data-orig-file=\"https:\/\/coronavirusbiblioh12o.files.wordpress.com\/2020\/05\/logo12.jpg\" data-orig-size=\"275,183\" data-comments-opened=\"1\" data-image-meta=\"{&quot;aperture&quot;:&quot;0&quot;,&quot;credit&quot;:&quot;&quot;,&quot;camera&quot;:&quot;&quot;,&quot;caption&quot;:&quot;&quot;,&quot;created_timestamp&quot;:&quot;0&quot;,&quot;copyright&quot;:&quot;&quot;,&quot;focal_length&quot;:&quot;0&quot;,&quot;iso&quot;:&quot;0&quot;,&quot;shutter_speed&quot;:&quot;0&quot;,&quot;title&quot;:&quot;&quot;,&quot;orientation&quot;:&quot;0&quot;}\" data-image-title=\"logo12\" data-image-description=\"\" data-medium-file=\"https:\/\/coronavirusbiblioh12o.files.wordpress.com\/2020\/05\/logo12.jpg?w=275\" data-large-file=\"https:\/\/coronavirusbiblioh12o.files.wordpress.com\/2020\/05\/logo12.jpg?w=275\" \/>es el t\u00edtulo de una carta enviada a la revista <em>International Journal of Laboratory Hematology<\/em> por un grupo de m\u00e9dicos investigadores del Servicio de Hematolog\u00eda del Hospital 12 de Octubre.<\/p>\n<p>Los pacientes con COVID-19, desde el punto de vista hematol\u00f3gico, suelen mostrar una coagulopat\u00eda con aumento del d\u00edmero D pero con baja incidencia de trombocitopenia y tendencia a desarrollar trombosis. Los autores han estudiado la posible participaci\u00f3n de la desintegrina ADAMTS13, prote\u00edna involucrada en la coagulaci\u00f3n, en la coagulopat\u00eda asociada con la COVID-19 y su papel en la gravedad y pron\u00f3stico de la infecci\u00f3n a partir de los datos de 100 pacientes hospitalizados con PCR positiva en la primera ola de la pandemia. Del total de pacientes, la mitad se clasific\u00f3 como enfermos graves y la otra mitad como no graves, su mediana de edad era de 60,5 % y el 70% eran varones, y todos ellos recibieron heparina como tratamiento. Los casos graves tuvieron una actividad de ADAMTS13 significativamente m\u00e1s baja y una concentraci\u00f3n plasm\u00e1tica de factor von Willebrand m\u00e1s alta. As\u00ed mismo, los casos con actividad de ADAMTS13 inferior al 61% mostraron una asociaci\u00f3n significativa con una menor supervivencia. Por ello, los autores concluyen que la actividad de ADAMTS13 podr\u00eda ser un marcador de pron\u00f3stico en pacientes con COVID-19.<\/p>\n<p><em>Equipo Biblioteca H12O<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u201cIncreased von Willebrand factor antigen and low ADAMTS13 activity are related to poor prognosis in covid\u201019 patients\u201d es el t\u00edtulo de una carta enviada a la revista International Journal of Laboratory Hematology por un grupo de m\u00e9dicos investigadores del Servicio de Hematolog\u00eda del Hospital 12 de Octubre. Los pacientes con \u2026<\/p>\n<p class=\"continue-reading-button\"> <a class=\"continue-reading-link\" href=\"https:\/\/cendoc.h12o.es\/blog\/2021\/02\/05\/adamts13-como-factor-de-pronostico-en-covid-19-y-h12o\/\">Continuar leyendo<i class=\"crycon-right-dir\"><\/i><\/a><\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","enabled":false},"version":2}},"categories":[4,64,46],"tags":[],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_shortlink":"https:\/\/wp.me\/p3G9TJ-H9","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/posts\/2675"}],"collection":[{"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/comments?post=2675"}],"version-history":[{"count":1,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/posts\/2675\/revisions"}],"predecessor-version":[{"id":2676,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/posts\/2675\/revisions\/2676"}],"wp:attachment":[{"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/media?parent=2675"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/categories?post=2675"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/tags?post=2675"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}